SANTA CLARA, Calif., August 20, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion ...
Qiagen and Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of individuals with a group of rare blood cancers known as myeloproliferative ...
The U.S. FDA recently convened an advisory hearing to discuss whether three in vitro diagnostics should be reclassified from class III to class II, including tests for the pathogens responsible for ...
Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy Authors retain all rights in any data ...
Hypertension is the main risk factor for cardiovascular disease (CVD), the most prevalent cause of unnecessary death and disability. Significant data suggests that early detection and management of ...
You feel unwell, and visit your doctor. They ask some questions and take some blood for testing; a few days later they call to say you have been diagnosed with a disease. What are the chances you ...
Blood tests have long been an important tool for giving doctors a picture of a patient’s health, from cholesterol levels to diabetes risk. Now new genetic science, AI analysis and other advances are ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback